Author: Paulina Linares
30/06/2022
Changes in hepatic fibrosis and incidence of HCC following direct-acting antiviral treatment of F3 chronic hepatitis c patients: a prospective observational study
Aim: Studies of clinical outcomes in chronic hepatitis C (CHC) patients with pretreatment advanced liver [...]
Read more14/07/2022
Missed the ILCA Single Topic Workshop?
The ILCA Single Topic Workshop (STW) focuses on a specific area in which recent developments have [...]
Read more07/07/2022
Top reasons to join ILCA AC2022
The premier forum for clinical, translational and basic researchers and physicians, as well as allied [...]
Read more01/06/2022
Impact of direct-acting antivirals on the recurrence of hepatocellular carcinoma in chronic hepatitis C
Chronic hepatitis C virus (HCV) infection is estimated to affect 56.8 million individuals globally and is a [...]
Read more21/06/2022
Update in Liver Resections for Primary Liver Cancer
In recent years, and with surgical and postoperative improvements, surgical approaches to liver cancer are [...]
Read more01/06/2022
ILCA School of Liver Cancer Chicago
The recent edition of the prestigious ILCA School of Liver Cancer has just been held and was an enormous [...]
Read more01/06/2022
Message from the President – May 2022
A single lecture does not make a workshop or a conference. What makes a workshop or a conference is [...]
Read more20/05/2022
Take a glance at this year’s Pre-Conference Workshop
The #ILCA22 Scientific Programme will kick-off on Thursday 1st with a full afternoon of Pre-Conference [...]
Read more16/05/2022
A focused review on recent advances in diagnosis and management of fibrolamellar hepatocellular carcinoma
Fibrolamellar hepatocellular carcinoma (FHCC) is a rare primary malignancy of the liver for which data [...]
Read more